These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21130593)

  • 1. Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2.
    Riaz S; Skinner V; Srai SK
    J Pharm Biomed Anal; 2011 Mar; 54(4):817-25. PubMed ID: 21130593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic identification of human urinary biomarkers in diabetes mellitus type 2.
    Riaz S; Alam SS; Srai SK; Skinner V; Riaz A; Akhtar MW
    Diabetes Technol Ther; 2010 Dec; 12(12):979-88. PubMed ID: 20735160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.
    Jain S; Rajput A; Kumar Y; Uppuluri N; Arvind AS; Tatu U
    J Assoc Physicians India; 2005 Jun; 53():513-20. PubMed ID: 16121805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of Protein Biomarkers of Diabetes Mellitus Type 2 and Therapy with Vitamin B1.
    Riaz S
    J Diabetes Res; 2015; 2015():150176. PubMed ID: 26273663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A discovery-phase urine proteomics investigation in type 1 diabetes.
    Soggiu A; Piras C; Bonizzi L; Hussein HA; Pisanu S; Roncada P
    Acta Diabetol; 2012 Dec; 49(6):453-64. PubMed ID: 22678621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic identification of urinary biomarkers of diabetic nephropathy.
    Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
    Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of urinary biomarkers for type 2 diabetes using bead-based proteomic approach.
    Chu L; Fu G; Meng Q; Zhou H; Zhang M
    Diabetes Res Clin Pract; 2013 Aug; 101(2):187-93. PubMed ID: 23769013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of immuno-unreactive intact albumin in urine of diabetic patients.
    Comper WD; Osicka TM; Jerums G
    Am J Kidney Dis; 2003 Feb; 41(2):336-42. PubMed ID: 12552494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis for the assessment of diabetic renal damage in humans.
    Mischak H; Kaiser T; Walden M; Hillmann M; Wittke S; Herrmann A; Knueppel S; Haller H; Fliser D
    Clin Sci (Lond); 2004 Nov; 107(5):485-95. PubMed ID: 15281910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study.
    Lapolla A; Seraglia R; Molin L; Williams K; Cosma C; Reitano R; Sechi A; Ragazzi E; Traldi P
    J Mass Spectrom; 2009 Mar; 44(3):419-25. PubMed ID: 19165811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics and diabetic nephropathy.
    Merchant ML; Klein JB
    Semin Nephrol; 2007 Nov; 27(6):627-36. PubMed ID: 18061845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring salivary proteomes in edentulous patients with type 2 diabetes.
    Border MB; Schwartz S; Carlson J; Dibble CF; Kohltfarber H; Offenbacher S; Buse JB; Bencharit S
    Mol Biosyst; 2012 Apr; 8(4):1304-10. PubMed ID: 22314925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial.
    Navarro JF; Mora C; Muros M; García J
    J Am Soc Nephrol; 2005 Jul; 16(7):2119-26. PubMed ID: 15917336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients.
    Guerrero-Romero F; Rodríguez-Morán M; Paniagua-Sierra JR; García-Bulnes G; Salas-Ramírez M; Amato D
    Clin Nephrol; 1995 Feb; 43(2):116-21. PubMed ID: 7736673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
    J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy.
    Sharma K; Lee S; Han S; Lee S; Francos B; McCue P; Wassell R; Shaw MA; RamachandraRao SP
    Proteomics; 2005 Jul; 5(10):2648-55. PubMed ID: 15984045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic identification of human serum biomarkers in diabetes mellitus type 2.
    Riaz S; Alam SS; Akhtar MW
    J Pharm Biomed Anal; 2010 Apr; 51(5):1103-7. PubMed ID: 20015604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.